Skip to search formSkip to main contentSkip to account menu

nipradilol

Known as: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
The stainless steel cannula inserting method was used to observe effects of nipradilol and prazosin on responses to periarterial… 
1986
1986
Nipradilol (NP) was metabolized mainly in liver and denitrated and/or hydroxylated metabolites were formed. NP was not… 
1986
1986
The cardiohemodynamic effects of nipradilol (K-351) were studied in comparison with those of propranolol, nadolol and prazosin in… 
1986
1986
The pharmacodynamic and pharmacological effects of nipradilol (K-351) were studied in a cross-over double blind fashion with… 
1985
1985
The pharmacokinetic parameters of nipradilol (NIP), a new potent antihypertensive and antianginal agent, and propranolol were… 
1985
1985
The metabolism and disposition of a new antihypertensive and antianginal agent, 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy… 
1985
1985
After oral administration of [14C]-labelled 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2H-1-b enzopyran… 
1985
1985
Effects of nipradilol (K-351) on cardiac performance and myocardial oxygen consumption were investigated in anesthetized open… 
1984
1984
Effects of nipradilol on proximal, middle and distal portions of left coronary arteries of the dog were investigated in vitro… 
1984
1984
Nipradilol but not desnitro nipradilol [N-) nipradilol) inhibited the norepinephrine (NE)-induced depolarization and contraction…